Study of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or Feet

NCT00585650 is an interventional clinical trial that is for Psoriasis conditions and was started in May of 2007. This trial has 6 people enrolled who are within the adult and senior age range. This trial is funded by an industry organization, and an outside organization. The specific sponsors / contributors of this trial are as follows: University of California, Irvine, and Amgen. The following interventions were used in this trial: (biological) Entercept. This trial is reported / scheduled to have been completed in May of 2008.